Related Experiment Video

Updated: Jul 17, 2026

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice
07:23

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice

Published on: December 20, 2024

[Clinical features, diagnosis and treatment of HIV-induced neuropsychiatric disorders]

Hans-Bernd Rothenhäusler1

  • 1Universitätsklinik für Psychiatrie der Medizinischen Universität Graz, Osterreich. Hans-Bernd.Rothenhaeusler@klinikum-graz.at

Wiener Medizinische Wochenschrift (1946)
|January 11, 2007
PubMed

Insights

Highly active antiretroviral therapy (HAART) has improved survival for individuals with human immunodeficiency virus (HIV) infection. However, HIV-associated neuropsychiatric disorders, including cognitive-motor impairments, remain a significant clinical challenge.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Psychiatry

Background:

  • Human immunodeficiency virus (HIV) infection has caused over 25 million deaths since 1981.
  • Highly active antiretroviral therapy (HAART), introduced in 1995, has reduced AIDS incidence in developed nations.
  • Improved survival due to HAART has highlighted the growing importance of HIV-associated neuropsychiatric disorders.

Purpose of the Study:

  • To provide an overview of HIV-induced cognitive-motor impairments.
  • To discuss the epidemiology, clinical features, diagnosis, and therapy of these disorders.

Main Methods:

  • Literature review of HIV-associated neuropsychiatric disorders.
  • Synthesis of current knowledge on HIV-induced cognitive-motor impairments.

Main Results:

  • HIV infection can lead to significant cognitive-motor impairments.
  • These impairments include HIV-associated dementia complex, organic mood disorders, and psychosis.
  • Effective diagnosis and management strategies are crucial for patient care.

Conclusions:

  • HIV-associated neuropsychiatric disorders are an increasing clinical concern.
  • Comprehensive understanding of epidemiology, clinical presentation, diagnosis, and treatment is essential.
  • Further research is needed to optimize management strategies for these complex conditions.

More Related Videos

A Rat Model of EcoHIV Brain Infection08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...